Cannabis use is associated with a lower likelihood of presence of HIV drug resistance mutations in a retrospective cohort of adults with HIV
The above results may suggest an immunomodulatory role for cannabis that impacts the propensity for ARV-DRM. These findings could incentivize future research to further investigate effects of cannabis use on the development of HIV ARV-DRM.
Authors
- Daohai Yu (ORCID: https://orcid.org/0000-0003-1034-3130)
- Jonathan F. Hale (ORCID: https://orcid.org/0000-0001-8136-1892)
- Heather R. Kates (ORCID: https://orcid.org/0000-0001-8490-2201)
- S.J Reynolds
- Servio H. Ramirez (ORCID: https://orcid.org/0000-0002-4609-5653)
- Allison M. Andrews (ORCID: https://orcid.org/0000-0003-1752-7450)
- Kelly A. Smith
- Mohammed M. Benmassaoud
- Roberto D. Palella
Institutions
- University of Florida (US)
- Temple University (US)
- Florida College (US)
Publication Details
- Journal
- NeuroImmune Pharmacology and Therapeutics
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1515/nipt-2024-0010
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute on Drug Abuse
- NIH Clinical Center